These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38529885)

  • 21. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent neurogenic thoracic outlet syndrome.
    Ambrad-Chalela E; Thomas GI; Johansen KH
    Am J Surg; 2004 Apr; 187(4):505-10. PubMed ID: 15041500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dilution, storage, and electromyographic guidance in the use of botulinum toxins.
    Mantell AM
    Dermatol Clin; 2004 Apr; 22(2):135-6, v. PubMed ID: 15222572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin: a review of applications for the head and neck.
    Seidman LM; Brooks JK; Bashirelahi N
    Gen Dent; 2019; 67(2):55-58. PubMed ID: 30875307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum Toxin A, a Better Choice for Skeletal Muscle Block in a Comparative Study With Lidocaine in Rats.
    Xu K; Zhang Z; Li Y; Song L; Gou J; Sun C; Li J; Du S; Cao R; Cui S
    J Pharmacol Exp Ther; 2022 Dec; 383(3):227-237. PubMed ID: 36116794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rib-sparing scalenectomy for neurogenic thoracic outlet syndrome: Early results.
    Johansen K
    J Vasc Surg; 2021 Jun; 73(6):2059-2063. PubMed ID: 33340695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
    Lang AM
    Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.
    Gottsch HP; Yang CC; Berger RE
    Scand J Urol Nephrol; 2011 Feb; 45(1):72-6. PubMed ID: 21062115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation and Management of Neurogenic Thoracic Outlet Syndrome with an Overview of Surgical Approaches: A Comprehensive Review.
    Lim C; Kavousi Y; Lum YW; Christo PJ
    J Pain Res; 2021; 14():3085-3095. PubMed ID: 34675637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applicability of botulinum toxin type A in paediatric neurogenic bladder management.
    Scheepe JR; Blok BF; 't Hoen LA
    Curr Opin Urol; 2017 Jan; 27(1):14-19. PubMed ID: 27748667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
    Blitzer A
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of botulinum toxin type B for migraine and tension headaches.
    Fadeyi MO; Adams QM
    Am J Health Syst Pharm; 2002 Oct; 59(19):1860-2. PubMed ID: 12374073
    [No Abstract]   [Full Text] [Related]  

  • 35. Combining ultrasonography and electromyography for botulinum chemodenervation treatment of thoracic outlet syndrome: comparison with fluoroscopy and electromyography guidance.
    Jordan SE; Ahn SS; Gelabert HA
    Pain Physician; 2007 Jul; 10(4):541-6. PubMed ID: 17660852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurogenic thoracic outlet and pectoralis minor syndromes in children.
    Sanders RJ; Annest SJ; Goldson E
    Vasc Endovascular Surg; 2013 Jul; 47(5):335-41. PubMed ID: 23503361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redo surgery for neurogenic thoracic outlet syndrome is useful.
    Goeteyn J; Van Der Sanden L; Pesser N; Houterman S; van Sambeek MRHM; van Nuenen BFL; Teijink JAW
    J Vasc Surg; 2022 Aug; 76(2):531-537.e1. PubMed ID: 35367561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity.
    Averbeck MA
    Int Braz J Urol; 2022; 48(6):988-989. PubMed ID: 36173410
    [No Abstract]   [Full Text] [Related]  

  • 39. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
    Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
    Koman LA; Paterson Smith B; Balkrishnan R
    Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.